Cite
Randomized controlled trial of ragweed sublingual immunotherapy tablet in the subpopulation of Canadian children and adolescents with allergic rhinoconjunctivitis.
MLA
Ellis, Anne K., et al. “Randomized Controlled Trial of Ragweed Sublingual Immunotherapy Tablet in the Subpopulation of Canadian Children and Adolescents with Allergic Rhinoconjunctivitis.” Allergy, Asthma & Clinical Immunology, vol. 17, no. 1, Dec. 2021, pp. 1–8. EBSCOhost, https://doi.org/10.1186/s13223-021-00626-2.
APA
Ellis, A. K., Gagnon, R., Bernstein, D. I., & Nolte, H. (2021). Randomized controlled trial of ragweed sublingual immunotherapy tablet in the subpopulation of Canadian children and adolescents with allergic rhinoconjunctivitis. Allergy, Asthma & Clinical Immunology, 17(1), 1–8. https://doi.org/10.1186/s13223-021-00626-2
Chicago
Ellis, Anne K., Remi Gagnon, David I. Bernstein, and Hendrik Nolte. 2021. “Randomized Controlled Trial of Ragweed Sublingual Immunotherapy Tablet in the Subpopulation of Canadian Children and Adolescents with Allergic Rhinoconjunctivitis.” Allergy, Asthma & Clinical Immunology 17 (1): 1–8. doi:10.1186/s13223-021-00626-2.